glp-1 cardiovascular outcomes trial results august 2025

glp-1 cardiovascular outcomes trial results august 2025 Comparative effectiveness of receptor agonists on among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target glp-1 cardiovascular outcomes trial results

Name: glp-1 cardiovascular outcomes trial results august 2025 Comparative effectiveness of receptor agonists on among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target glp-1 cardiovascular outcomes trial results
Brand: actil.am
SKU: 24403062917
Price: 28.13 USD
Availability: InStock
Rating: 4.0324 (8 reviews)

SKU: 24403062917

4.0

USD28.13 USD69.13

Pay in 4 interest-free payments of $7.03 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 2 - Sep 7

Description

Hao HF, et al

As a GLP-1 receptor agonist, GLP-1 and GLP-2 binds to the GLP-1 receptors, modulating the physiological processes crucial for maintaining blood glucose levels, especially postprandial glucose levels

Foyer CH